Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Cantargia receives patent approval in Japan and Mexico

The patent application covers IL1RAP as a target molecule for antibody therapy and leukemia diagnostics. The IL1RAP originates from the research of Prof Thoas Fioretos.

Latest articles

18/09/2017
Lunds Fernströmpris till forskning om cancercellers samspel med omgivningen
Lunds Fernströmpris till forskning om cancercellers samspel med omgivningen
29/08/2017
Improved gene analysis of kidney cancer defines kidney cancer subtypes
Improved gene analysis of kidney cancer defines kidney cancer subtypes
13/06/2016
New variants of blood cancer in children
New variants of blood cancer in children
04/05/2016
A breakthrough of professor Kristian Pietras highlighted by Cancerfonden
A breakthrough of professor Kristian Pietras highlighted by Cancerfonden
08/04/2016
CREATE Health research in "Cancerfondsrapporten 2016"
CREATE Health research in "Cancerfondsrapporten 2016"